Failure to diagnose hypochondroplasia by prenatal diagnosis: a case report

Abstract Background Hypochondroplasia (HCH) is a common nonlethal skeletal dysplasia caused by pathogenic variations in the fibroblast growth factor receptor 3 (FGFR3) gene, and HCH has similar clinical manifestations with achondroplasia (ACH), which can be screened during the fetal period by prenat...

Full description

Bibliographic Details
Main Authors: Hua Xie, Yulin Chen, Fei Xiong, Jinrong Li, Fan Yang
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Pediatrics
Subjects:
Online Access:https://doi.org/10.1186/s12887-023-03917-2
_version_ 1797863559539982336
author Hua Xie
Yulin Chen
Fei Xiong
Jinrong Li
Fan Yang
author_facet Hua Xie
Yulin Chen
Fei Xiong
Jinrong Li
Fan Yang
author_sort Hua Xie
collection DOAJ
description Abstract Background Hypochondroplasia (HCH) is a common nonlethal skeletal dysplasia caused by pathogenic variations in the fibroblast growth factor receptor 3 (FGFR3) gene, and HCH has similar clinical manifestations with achondroplasia (ACH), which can be screened during the fetal period by prenatal ultrasound testing and diagnosed by genetic testing. Case presentation we report the special case of a patient with obvious growth retardation and rhizomelic disproportionate short stature, accompanied by other manifestations, including an enlarged head and short hands at 1 year old. However, several multiple color ultrasound exams identified shortened limbs (< 3rd percentile), an increased biparietal diameter (> 95th percentile) and a low nasal bridge in the fetal period. Due to the high incidence rate of ACH, genetic testing for the hotspot FGFR3 gene c.1138 g > A pathogenic variations was performed immediately in the third trimester. Unfortunately, the definitive diagnosis could not be made before birth due to the negative result of hotspot gene exam. Whole exome sequencing (WES) was performed at 1 year identified FGFR3 gene c.1620C > A variations positivity, and the patient was finally diagnosed as HCH. Conclusion Our report extends the understanding of the limitations of prenatal genetic diagnostic testing, especially the hot spot pathogenic variations test should be not the only clinical diagnostic basis. Moreover, this case also emphasizes that further gene analysis for patients with significant conflict between the clinical manifestation and the prenatal genetic panel examination findings should be reconducted timely to spare the family from a delayed diagnosis or a misdiagnosis.
first_indexed 2024-04-09T22:37:25Z
format Article
id doaj.art-b55f5b774dab4645a63430aa7e285dee
institution Directory Open Access Journal
issn 1471-2431
language English
last_indexed 2024-04-09T22:37:25Z
publishDate 2023-03-01
publisher BMC
record_format Article
series BMC Pediatrics
spelling doaj.art-b55f5b774dab4645a63430aa7e285dee2023-03-22T12:23:59ZengBMCBMC Pediatrics1471-24312023-03-012311610.1186/s12887-023-03917-2Failure to diagnose hypochondroplasia by prenatal diagnosis: a case reportHua Xie0Yulin Chen1Fei Xiong2Jinrong Li3Fan Yang4Department of Pediatrics, West China Second University Hospital, Sichuan UniversityDoctorate of Health Management Program, National University of Science and Technology MISISDepartment of Pediatrics, West China Second University Hospital, Sichuan UniversityDepartment of Pediatrics, West China Second University Hospital, Sichuan UniversityDepartment of Pediatrics, West China Second University Hospital, Sichuan UniversityAbstract Background Hypochondroplasia (HCH) is a common nonlethal skeletal dysplasia caused by pathogenic variations in the fibroblast growth factor receptor 3 (FGFR3) gene, and HCH has similar clinical manifestations with achondroplasia (ACH), which can be screened during the fetal period by prenatal ultrasound testing and diagnosed by genetic testing. Case presentation we report the special case of a patient with obvious growth retardation and rhizomelic disproportionate short stature, accompanied by other manifestations, including an enlarged head and short hands at 1 year old. However, several multiple color ultrasound exams identified shortened limbs (< 3rd percentile), an increased biparietal diameter (> 95th percentile) and a low nasal bridge in the fetal period. Due to the high incidence rate of ACH, genetic testing for the hotspot FGFR3 gene c.1138 g > A pathogenic variations was performed immediately in the third trimester. Unfortunately, the definitive diagnosis could not be made before birth due to the negative result of hotspot gene exam. Whole exome sequencing (WES) was performed at 1 year identified FGFR3 gene c.1620C > A variations positivity, and the patient was finally diagnosed as HCH. Conclusion Our report extends the understanding of the limitations of prenatal genetic diagnostic testing, especially the hot spot pathogenic variations test should be not the only clinical diagnostic basis. Moreover, this case also emphasizes that further gene analysis for patients with significant conflict between the clinical manifestation and the prenatal genetic panel examination findings should be reconducted timely to spare the family from a delayed diagnosis or a misdiagnosis.https://doi.org/10.1186/s12887-023-03917-2HypochondroplasiaFibroblast growth factor receptor 3Sanger sequencingCase report
spellingShingle Hua Xie
Yulin Chen
Fei Xiong
Jinrong Li
Fan Yang
Failure to diagnose hypochondroplasia by prenatal diagnosis: a case report
BMC Pediatrics
Hypochondroplasia
Fibroblast growth factor receptor 3
Sanger sequencing
Case report
title Failure to diagnose hypochondroplasia by prenatal diagnosis: a case report
title_full Failure to diagnose hypochondroplasia by prenatal diagnosis: a case report
title_fullStr Failure to diagnose hypochondroplasia by prenatal diagnosis: a case report
title_full_unstemmed Failure to diagnose hypochondroplasia by prenatal diagnosis: a case report
title_short Failure to diagnose hypochondroplasia by prenatal diagnosis: a case report
title_sort failure to diagnose hypochondroplasia by prenatal diagnosis a case report
topic Hypochondroplasia
Fibroblast growth factor receptor 3
Sanger sequencing
Case report
url https://doi.org/10.1186/s12887-023-03917-2
work_keys_str_mv AT huaxie failuretodiagnosehypochondroplasiabyprenataldiagnosisacasereport
AT yulinchen failuretodiagnosehypochondroplasiabyprenataldiagnosisacasereport
AT feixiong failuretodiagnosehypochondroplasiabyprenataldiagnosisacasereport
AT jinrongli failuretodiagnosehypochondroplasiabyprenataldiagnosisacasereport
AT fanyang failuretodiagnosehypochondroplasiabyprenataldiagnosisacasereport